AN2 Therapeutics vs Enterome

AN2 Therapeutics vs Enterome, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AN2 Therapeutics is on 46/100 and Enterome on 60/100.

AN2 Therapeutics logo
AN2 TherapeuticsClinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.
Try AN2 Therapeutics
Enterome logo
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Try Enterome

Where each one leads

AN2 Therapeutics

  • agent readiness: 32/100 against 21/100

Enterome

  • our overall score: 60/100 against 46/100
  • domain rating: 46/100 against 29/100

At a glance

MeasureAN2 TherapeuticsEnterome
What it isClinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
CategoryBiotechnology, Pharmaceuticals, Healthcare, Drug DiscoveryBiotechnology, Drug Discovery, Oncology, Immunotherapy
Sells toBusiness modelB2BB2B
OfferingBiopharmaceuticalSoftware | hardware | services | marketplace | platform
Founded20182012
HeadquartersMenlo Park, United StatesParis, France
StatusActiveActive

Size, funding and growth

MeasureAN2 TherapeuticsEnterome
EmployeesNot published33
Total funding$132M$124M
Latest roundPrivate PlacementLater Stage VC
Valuation$1.1BNot published
LinkedIn followersNot published16,846

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAN2 TherapeuticsEnterome
StartupHub scoreOur 0-100 rating46/10060/100
Traction40/10055/100
Team70/10070/100
Search visibility12/10034/100
Quality55/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (32/100)F (21/100)
Domain ratingLink authority, 0-10029/10046/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAN2 TherapeuticsEnterome
HostingAWSSelf Managed
CMSNot detectedWordPress
FrameworksJqueryBootstrap
AnalyticsGoogle Analytics 4Google Analytics 4, Segment

AN2 Therapeutics vs Enterome: common questions

Which is better, AN2 Therapeutics or Enterome?

On our 0-100 score Enterome rates higher (60/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do AN2 Therapeutics and Enterome compare on the numbers?

AN2 Therapeutics leads on agent readiness (32/100 against 21/100). Enterome leads on our overall score (60/100 against 46/100), domain rating (46/100 against 29/100).

Read the full AN2 Therapeutics review and pricing or the Enterome review and pricing. You can also browse other AN2 Therapeutics alternatives we track.